Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Scented candles as an unrecognised factor that increases the risk of bladder cancer; is there enough evidence to raise a red flag?

Adamowicz J, Juszczak K, Poletajew S, van Breda SV, Pokrywczynska M, Drewa T.

Cancer Prev Res (Phila). 2019 Aug 9. pii: canprevres.0093.2019. doi: 10.1158/1940-6207.CAPR-19-0093. [Epub ahead of print]

PMID:
31399420
2.

Urinary bladder hypertrophy and overactive bladder determine urinary continence after radical prostatectomy.

Juszczak K, Ostrowski A, Adamowicz J, Maciukiewicz P, Drewa T.

Adv Clin Exp Med. 2019 Mar 14. doi: 10.17219/acem/104532. [Epub ahead of print]

PMID:
30880375
3.

Constructing artificial urinary conduits: current capabilities and future potential.

Adamowicz J, Van Breda SV, Kloskowski T, Juszczak K, Pokrywczynska M, Drewa T.

Expert Rev Med Devices. 2019 Feb;16(2):135-144. doi: 10.1080/17434440.2019.1562901. Epub 2019 Jan 11. Review.

PMID:
30588868
4.

Elastography in prostate gland imaging and prostate cancer detection.

Tyloch DJ, Tyloch JF, Adamowicz J, Juszczak K, Ostrowski A, Warsiński P, Wilamowski J, Ludwikowska J, Drewa T.

Med Ultrason. 2018 Dec 8;20(4):515-523. doi: 10.11152/mu-1655. Review.

5.

Clinical outcomes of intravesical injections of botulinum toxin type A in patients with refractory idiopathic overactive bladder.

Juszczak K, Adamczyk P, Maciukiewicz P, Drewa T.

Pharmacol Rep. 2018 Dec;70(6):1133-1138. doi: 10.1016/j.pharep.2018.08.002. Epub 2018 Aug 2.

PMID:
30317128
6.

A hypothesis for the mechanism of urine incontinence in patients after radical prostatectomy due to urinary bladder hypertrophy.

Juszczak K, Ostrowski A, Bryczkowski M, Adamczyk P, Drewa T.

Adv Clin Exp Med. 2019 Mar;28(3):347-351. doi: 10.17219/acem/79935. Review.

7.

Correlation between malnutrition, body mass index and complications in patients with urinary bladder cancer who underwent radical cystectomy.

Swalarz M, Swalarz G, Juszczak K, Maciukiewicz P, Czurak K, Matuszewski M, Gajewska D, Słojewski M, Bogacki R, Bryniarski P, Paradysz A, Kadłubowski M, Drewa T, Genge E.

Adv Clin Exp Med. 2018 Aug;27(8):1141-1147. doi: 10.17219/acem/89863.

8.

Robot-assisted radical cystectomy - first Polish clinical outcomes.

Adamczyk P, Juszczak K, Poblocki P, Mikolajczak W, Drewa T.

Cent European J Urol. 2018;71(1):14-20. doi: 10.5173/ceju.2018.1628. Epub 2017 Feb 15.

9.
10.

Fluoroquinolone-resistant Escherichia coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy - possible shift in biopsy prophylaxis.

Adamczyk P, Juszczak K, Prondzinska M, Kędzierska A, Szwajkert-Sobiecka H, Drewa T.

Cent European J Urol. 2017 Jun 30;70(2):192-196. doi: 10.5173/ceju.2017.739. Epub 2017 Jun 11.

11.

Altered sympathovagal balance and pain hypersensitivity in TNBS-induced colitis.

Ciesielczyk K, Furgała A, Dobrek Ł, Juszczak K, Thor P.

Arch Med Sci. 2017 Feb 1;13(1):246-255. doi: 10.5114/aoms.2015.55147. Epub 2016 Dec 19.

12.

Urological procedures in Central Europe and the current reality based on the national registries of Czech Republic, Hungary, and Poland (2012 status).

Adamczyk P, Juszczak K, Drewa T, Hora M, Nyirády P, Sosnowski M.

Cent European J Urol. 2016;69(4):327-333. doi: 10.5173/ceju.2016.886. Epub 2016 Nov 30.

13.

Rare neoplasm of genito-urinary tract. Genito-urinary sarcomas: chemotherapy.

Adamczyk P, Juszczak K, Drewa T.

Curr Opin Urol. 2017 Jan;27(1):80-84. Review.

PMID:
27798413
14.
15.

Pharmacotherapy in detrusor underactivity: A new challenge for urologists and pharmacologists (from lab to clinic).

Juszczak K, Drewa T.

Pharmacol Rep. 2016 Aug;68(4):703-6. doi: 10.1016/j.pharep.2016.03.007. Epub 2016 Mar 19. Review.

PMID:
27110877
16.

The role of the peripheral cannabinoid system in the pathogenesis of detrusor overactivity evoked by increased intravesical osmolarity in rats.

Juszczak K, Maciukiewicz P.

Can J Physiol Pharmacol. 2015 Aug;93(8):721-6. doi: 10.1139/cjpp-2015-0091. Epub 2015 Apr 13.

PMID:
26243021
17.
18.

Not only diabetic polyneuropathy but also interstitial cells of Cajal dysfunction is a potential mechanism for diabetic cystopathy.

Juszczak K.

Cent European J Urol. 2014;67(4):375-6. doi: 10.5173/ceju.2014.04.art11. No abstract available.

19.

The presence of LUTS is not a decisive tool for deciding who should be qualified for prostate biopsy.

Juszczak K.

Cent European J Urol. 2014;67(2):182-3. doi: 10.5173/ceju.2014.02.art12. No abstract available.

20.

Adrenergic crisis due to pheochromocytoma - practical aspects. A short review.

Juszczak K, Drewa T.

Cent European J Urol. 2014;67(2):153-5. doi: 10.5173/ceju.2014.02.art7. Epub 2014 Jun 23. Review.

21.

Postoperative evaluation of hydronephrosis due to the way of pyeloplasy (dismembered / non-dismembered).

Matuszewski M, Drewniak T, Juszczak K.

Cent European J Urol. 2014;67(1):106-7. doi: 10.5173/ceju.2014.01.art25. No abstract available.

22.

Do urologists need an orthodontist in order to optimize the treatment of nocturnal enuresis?

Juszczak K.

Cent European J Urol. 2014;67(1):56-7. doi: 10.5173/ceju.2014.01.art12. No abstract available.

23.

Cajal-like interstitial cells as a novel target in detrusor overactivity treatment: true or myth?

Juszczak K, Maciukiewicz P, Drewa T, Thor PJ.

Cent European J Urol. 2014;66(4):413-7. doi: 10.5173/ceju.2013.04.art5. Epub 2014 Jan 27. Review.

24.

Methodology and evaluation of the renal arterial system.

Drewniak T, Rzepecki M, Juszczak K, Moczulski Z, Reczyńska K, Jakubowska M.

Cent European J Urol. 2013;66(2):152-7. doi: 10.5173/ceju.2013.02.art10. Epub 2013 Aug 13.

25.

[The use of hemostatic agent Tachosil in surgical treatment of kidney cancer infiltrating liver--case report].

Drewniak T, Rzepecki M, Juszczak K, Jakubowski J, Sandheim M, Maciukiewicz P.

Pol Merkur Lekarski. 2013 Jun;34(204):345-7. Polish.

PMID:
23882933
26.

[Smoking among youths and parents attitudes in this phenomenon].

Juszczak K, Gawłowicz K, Jachimowicz V.

Przegl Lek. 2012;69(10):861-2. Polish.

PMID:
23421047
27.
28.

Prognostic factors of overall survival in renal cancer patients - single oncological center study.

Drewniak T, Sandheim M, Jakubowski J, Juszczak K, Stelmach AW.

Cent European J Urol. 2013;66(3):283-91. doi: 10.5173/ceju.2013.03.art9. Epub 2013 Nov 18.

29.

Stem cells - the key to cancer treatment.

Juszczak K, Maciukiewicz P.

Cent European J Urol. 2013;66(3):281-2. doi: 10.5173/ceju.2013.03.art8. No abstract available.

31.

Pulsed electromagnetic field affects intrinsic and endoplasmatic reticulum apoptosis induction pathways in MonoMac6 cell line culture.

Kaszuba-Zwoinska J, Chorobik P, Juszczak K, Zaraska W, Thor PJ.

J Physiol Pharmacol. 2012 Oct;63(5):537-45.

32.
33.

[Selected markers of oxidative stress and carcinogenic trace elements concentrations in the renal cell carcinoma tissue].

Drewniak T, Wajdowicz A, Kwiatek W, Juszczak K, Maciukiewicz P.

Pol Merkur Lekarski. 2012 Jun;32(192):378-81. Polish.

PMID:
22891563
34.

Morphological and urodynamic evaluation of urinary bladder wall regeneration: muscles guarantee contraction but not proper function--a rat model research study.

Adamowicz J, Juszczak K, Bajek A, Tworkiewicz J, Nowacki M, Marszalek A, Thor PJ, Chlosta P, Drewa T.

Transplant Proc. 2012 Jun;44(5):1429-34. doi: 10.1016/j.transproceed.2012.01.144.

PMID:
22664029
35.

The effect of hyperosmolar stimuli and cyclophosphamide on the culture of normal rat urothelial cells in vitro.

Juszczak K, Kaszuba-Zwoińska J, Chorobik P, Ziomber A, Thor PJ.

Cell Mol Biol Lett. 2012 Jun;17(2):196-205. doi: 10.2478/s11658-012-0002-y.

36.

New insights into salt-sensitive hypertension.

Ziomber A, Juszczak K, Thor P.

Folia Med Cracov. 2012;52(3-4):61-6.

PMID:
24852687
37.

Laboratory diagnostics of renal function in an experimental model of ascending pyelonephritis with high-virulent Escherichia coli.

Skowron B, Juszczak K, Baranowska A, Machowska A, Strus M, Wiecek G, Heczko P, Thor PJ.

Folia Med Cracov. 2012;52(1-2):25-37.

PMID:
23697213
39.

Current management and future perspectives of overactive bladder (OAB) pharmacotherapy.

Dobrek Ł, Juszczak K, Wyczółkowski M, Thor PJ.

Acta Pol Pharm. 2011 Nov-Dec;68(6):807-21. Review.

40.

[Evaluation of 99mTc-DTPA scyntygraphy of the relative degree of renal dysfunction after surgical removal of kidney tumor].

Drewniak T, Juszczak K, Maciukiewicz P, Wyczółkowski M.

Pol Merkur Lekarski. 2011 Oct;31(184):209-11. Polish.

PMID:
22097176
41.

[Urological surgical technique using image guided therapy].

Drewniak T, Wyczołkowski M, Juszczak K.

Pol Merkur Lekarski. 2011 Aug;31(182):122-6. Review. Polish.

PMID:
21936352
43.

The ameliorating effect of exogenous melatonin on urinary bladder function in hyperosmolar bladder overactivity and its influence on the autonomic nervous system activity.

Juszczak K, Ziomber A, Machowska A, Furgała A, Dobrek Ł, Wyczółkowski M, Thor PJ.

Acta Medica (Hradec Kralove). 2011;54(2):63-8.

44.

[Drug induced man infertility].

Skowron B, Juszczak K, Thor PJ.

Folia Med Cracov. 2011;51(1-4):99-106. Review. Polish.

PMID:
22891542
45.

[Capsaicin and lidocaine usage in functional disorders of urinary bladder].

Juszczak K, Thor PJ.

Folia Med Cracov. 2011;51(1-4):91-8. Review. Polish.

PMID:
22891541
46.

[Augmented reality for image guided therapy (ARIGT) of kidney tumor during nephron sparing surgery (NSS): animal model and clinical approach].

Drewniak T, Rzepecki M, Juszczak K, Kwiatek W, Bielecki J, Zieliński K, Ruta A, Czekierda Ł, Moczulskis Z.

Folia Med Cracov. 2011;51(1-4):77-90. Polish.

PMID:
22891540
47.

[Electric activity of vagus nerve in rats according to satiety].

Zaraska K, Ziomber A, Ciesielczyk K, Bugajski A, Wiśniewska O, Skowron B, Juszczak K, Zaraska W, Thor PJ.

Folia Med Cracov. 2011;51(1-4):5-17. Polish.

PMID:
22891533
48.

Studer orthotopic ileal bladder substitute construction - surgical technique and complication management: one-center and 12-year experience.

Wyczółkowski M, Juszczak K, Rzepecki M, Drewniak T, Klima W.

Adv Med Sci. 2010;55(2):146-52. doi: 10.2478/v10039-010-0051-2.

PMID:
21147696
49.

Hyperosmolarity alters micturition: a comparison of urinary bladder motor activity in hyperosmolar and cyclophosphamide-induced models of overactive bladder.

Juszczak K, Ziomber A, Wyczółkowski M, Thor PJ.

Can J Physiol Pharmacol. 2010 Sep;88(9):899-906. doi: 10.1139/y10-072.

PMID:
20921976
50.

Functional, histological structure and mastocytes alterations in rat urinary bladders following acute and [corrected] chronic cyclophosphamide treatment.

Juszczak K, Gil K, Wyczolkowski M, Thor PJ.

J Physiol Pharmacol. 2010 Aug;61(4):477-82. Erratum in: J Physiol Pharmacol. 2011 Feb;62(1):131-3.

Supplemental Content

Loading ...
Support Center